e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CareDx, Inc. - Common Stock
(NQ:
CDNA
)
88.24
+2.36 (+2.75%)
Delayed Quote
Updated: 11:57 AM EST, Nov 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CareDx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
CareDx (NASDAQ:CDNA): A Case for Affordable Growth
↗
Today 7:30 EST
Via
Chartmill
Why CareDx Stock Soared Today
↗
October 30, 2026
The precision medicine pioneer is helping to improve patient care.
Via
The Motley Fool
Gap-Up and Gap-Down Stocks for October 30, 2026
↗
October 30, 2026
Via
Chartmill
CareDx (CDNA) Q3 2026 Earnings Call Transcript
↗
October 30, 2026
Testing volumes surged 51% as NavDx integration drove revenue and margin gains.
Via
The Motley Fool
Topics
Earnings
CareDx (NASDAQ:CDNA): Strong Growth Meets Technical Setup Quality
↗
October 27, 2026
Via
Chartmill
CareDx (NASDAQ:CDNA) Stands Out for High Growth and Improving Fundamentals
↗
October 12, 2026
Via
Chartmill
CAREDX INC (NASDAQ:CDNA): High Growth and Improving Fundamentals Fuel Bullish Case
↗
September 19, 2026
Via
Chartmill
CareDx (NASDAQ:CDNA) Meets Minervini Trend Template with High-Growth Momentum
↗
September 10, 2026
Via
Chartmill
CareDx (NASDAQ:CDNA) Screens Well on High Growth Momentum and Breakout Setup
↗
September 05, 2026
Via
Chartmill
What CareDx (CDNA) Said on Its Q3 Earnings Call
↗
October 29, 2026
CareDx (NASDAQ:CDNA) reported third-quarter 2026 revenue growth of 39% as testing volumes increased, driven by its transplant business and the addition of Specialty Oncology testing following the July...
Via
MarketBeat
Topics
Earnings
After-Hours Market Movers: Oct. 29, 2026 Gainers and Losers
↗
October 29, 2026
Via
Chartmill
CareDx (NASDAQ:CDNA) Shows Strong Growth Fundamentals by Passing All Eight Rules of Navellier's Screen
↗
August 28, 2026
Via
Chartmill
CareDx (NASDAQ:CDNA) Combines Strong Growth With a Bullish Technical Setup
↗
August 25, 2026
Via
Chartmill
CareDx (NASDAQ:CDNA) Passes Minervini Trend Template and High Growth Momentum Screen
↗
August 19, 2026
Via
Chartmill
CareDx (NASDAQ:CDNA) Posts Accelerating Growth and Strengthening Fundamentals
↗
August 06, 2026
Via
Chartmill
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests
↗
June 20, 2026
Via
Chartmill
CAREDX INC (NASDAQ:CDNA) Shows Perfect Minervini Trend Template and High Growth Momentum Setup
↗
May 30, 2026
Via
Chartmill
CareDx (NASDAQ:CDNA) Beats Q1 Estimates and Raises Full-Year Guidance, But Stock Slips
↗
April 28, 2026
Via
Chartmill
Why CareDx Stock Jumped Today
↗
July 31, 2026
The diagnostics leader is accelerating the trend toward precision medicine.
Via
The Motley Fool
CareDx Q2 Earnings Call Highlights
↗
July 30, 2026
CareDx (NASDAQ:CDNA) reported second-quarter 2026 revenue growth of 52% as the transplant diagnostics company expanded testing services, completed the sale of its lab products business and began...
Via
MarketBeat
Topics
Earnings
What's going on in today's session
↗
July 16, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
July 16, 2026
Via
Chartmill
CareDx's CEO Sells 17K Shares
↗
June 21, 2026
CareDx, a leader in transplant diagnostics, saw a key insider reduce his direct holdings amid a series of scheduled transactions.
Via
The Motley Fool
Topics
Regulatory Compliance
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans
↗
June 08, 2026
CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted...
Via
MarketBeat
Topics
Intellectual Property
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies
↗
June 07, 2026
CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing...
Via
MarketBeat
CareDx (CDNA) Q1 2026 Earnings Call Transcript
↗
April 28, 2026
CareDx (CDNA) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Get insights into the top gainers and losers of Tuesday's after-hours session.
↗
April 28, 2026
Via
Chartmill
CareDx (CDNA) Q2 2025 Earnings Transcript
↗
April 28, 2026
CareDx (CDNA) Q2 2025 Earnings Transcript
Via
The Motley Fool
Thursday's session: gap up and gap down stocks
↗
April 16, 2026
Via
Chartmill
CareDx (CDNA) Q4 2025 Earnings Call Transcript
↗
February 24, 2026
CareDx (CDNA) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.